Theriva Biologics, Inc. Increase (Decrease) in Accounts Receivable
Theriva Biologics, Inc. (TOVX) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2015-03-16
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for the quarter ending 2013-12-31 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for the quarter ending 2013-09-30 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for the quarter ending 2013-06-30 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for fiscal 2014 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for fiscal 2013 was $0.00.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for fiscal 2012 was -$14.00K, a 102.92% decline from fiscal 2011.
- Theriva Biologics, Inc. increase (decrease) in accounts receivable for fiscal 2011 was $480.00K, a 9.59% increase from fiscal 2010.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | -$19.00K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | -$19.00K derived: sum of 3 quarters · filed 2015-03-16 | -$57.00K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$19.00K derived: sum of 2 quarters · filed 2015-03-16 | -$57.00K derived: sum of 3 quarters · filed 2015-03-16 | -$14.00K 10-K · filed 2015-03-16 | ||
| 2012-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$57.00K derived: sum of 2 quarters · filed 2013-11-14 | -$14.00K 10-Q · filed 2013-11-14 | $55.00K derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $5.00K 10-Q · filed 2013-08-14 | $74.00K derived: sum of 3 quarters · filed 2013-08-14 | $190.00K derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2012-03-31 | $43.00K 10-Q · filed 2013-05-15 | $112.00K derived: sum of 2 quarters · filed 2013-05-15 | $228.00K derived: sum of 3 quarters · filed 2013-05-15 | $412.00K derived: sum of 4 quarters · filed 2013-05-15 | ||
| 2011-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $185.00K derived: sum of 2 quarters · filed 2013-04-16 | $369.00K derived: sum of 3 quarters · filed 2013-04-16 | $480.00K 10-K · filed 2013-04-16 | ||
| 2011-09-30 | $116.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $300.00K derived: sum of 2 quarters · filed 2012-11-14 | $411.00K 10-Q · filed 2012-11-14 | $410.64K 10-Q · filed 2011-11-14 | $241.78K derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $184.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-11 | $295.00K 10-Q/A · filed 2012-09-11 | $294.62K 10-Q · filed 2011-08-15 | $125.78K derived: sum of 3 quarters · filed 2012-09-11 | $579.43K derived: sum of 4 quarters · filed 2012-09-11 | |
| 2011-03-31 | $111.00K 10-Q · filed 2012-05-15 | -$58.23K derived: sum of 2 quarters · filed 2012-05-15 | $395.43K derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | -$169.22K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $284.43K derived: sum of 2 quarters · filed 2012-05-11 | $438.00K 10-K/A · filed 2012-05-11 | |||
| 2010-09-30 | $453.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $607.23K 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $153.57K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |